Raynaud's phenomenon and acral necrosis after chemotherapy for AIDS-related Kaposi's sarcoma

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 17, Issue 1, 1998, Pages 58-60

  Reiser, M ^a   Bruns, C ^a   Hartmann, P ^a   Salzberger, B ^a   Diehl, V ^a   Fatkenheuer G ^a  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; VINBLASTINE; VINCRISTINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; GANGRENE; HUMAN; KAPOSI SARCOMA; MALE; NECROSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAYNAUD PHENOMENON;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; FINGERS; GANGRENE; HUMANS; MALE; RAYNAUD DISEASE; SARCOMA, KAPOSI; VINBLASTINE; VINCRISTINE;

EID: 0031896262     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01584368     Document Type: Article

References (12)

1. Vogelzang NJ, Bosl GJ, Johnson K, Kennedy BJ: Raynaud's phenomenon: a common toxicity after combination chemotherapy for testicular cancer. Annals of Internal Medicine 1981, 95: 288-292.
2. Fertakos RJ, Mintzer DM: Digital gangrene following chemotherapy for AIDS-related Kaposi's sarcoma. American Journal of Medicine 1992, 93: 581-582.
3. Elomaa I, Pajunen M, Virkkunen P: Raynaud's phenomenon progressing to gangrene after vincristine and bleomycin therapy. Acta Medica Scandinavica 1984, 216: 323-326.
4. Cohen IS, Mosher MB, O'Keefe EJ, Klaus SN, DeConti RC: Cutaneous toxicity of bleomycin therapy. Archives of Dermatology 1973, 107: 553-555.
5. Vayssairat M, Gaitz JP, Bamberger N: Digital gangrene, HIV infection, and bleomycin treatment. Journal of Rheumatology 1993, 20: 921.
6. Lafeuillade A, Alessi MC, Poizot-Martin I, Dhiver C, Quilichini R, Aubert L, Gastaut JA, Juahan-Vague I: Protein S deficiency and HIV infection. New England Journal of Medicine 1991, 324: 1220.
7. Werquin S, Kacet S, Caron J, Lacroix D, Libersa C, Coget JM, Lekieffre J: Phenomene de Raynaud et necrose digitale apres traitement d'un seminome ovarien par bleomycine, vinblastine et 5-fluoro-uracile (Raynaud's phenomenon and finger necrosis after treatment of ovarian seminoma with bleomycin, vinblastine, and 5-fluorouracil). Annales de Cardiologie et de Angeiologie 1987, 36: 409-412.
8. Toumbis-loannou E, Cohen PR: Chemotherapy-induced Raynaud's phenomenon. Cleveland Clinic Journal of Medicine 1994, 61: 195-199.
9. Hansen SW, Olsen N: Raynaud's phenomenon in patients treated with cisplatinum, vinblastine, and bleomycin for germ cell cancer: measurement of vasoconstrictor response to cold. Journal of Clinical Oncology 1989, 7: 940-942.
10. Finch WR, Rodnan GP, Buckingham RB, Prince RK, Winkelstein A: Bleomycin-induced scleroderma. Journal of Rheumatology 1980, 7: 651-659.
11. Bellmunt J, Navarro M, Morales S: Capillary microscopy is a potentially useful method for detecting bleomycin vascular toxicity. Cancer 1990, 65: 303-309.
12. Caumes E, Katlama C, Guermonprez G, Bournerias I, Danis M, Gentilini M: Cutaneous side-effects of bleomycin in AIDS patients with Kaposi's sarcoma. Lancet 1990, 336: 1593.